Fast discharge strategy: Patients undergoing invasive management after myocardial infarction will be discharged after 24 (+/- 12) hours.
Study summary
To evaluate the hypothesis that a fast discharge strategy (discharge at 24 \[± 12\] hours) following invasive management for acute myocardial infarction is non-inferior to standard of care (\>36 hours) with respect to the risk of major adverse cardiovascular events (MACE) during follow-up.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Uncomplicated acute myocardial infarction (NSTEMI and STEMI) diagnosed according to the 2023 acute coronary syndrome guidelines of the ESC
* Age ≥ 18 years at time of consent
* Invasive management strategy and in case of PCI successful intervention of the culprit lesion defined by post-interventional TIMI 3 flow
* Ability to understand and willingness to sign and date written informed consent
Exclusion Criteria:
* Myocardial infarction complicated by cardiac arrest (out-of-hospital cardiac arrest/in-hospital cardiac arrest)
* PCI-related complications (coronary perforation, side branch closure, inability to deliver stent/balloon, aortic dissection, allergic reaction grade ≥2, stroke/thromboembolism, access site complications including pseudoaneurysm, arteriovenous fistula, retroperitoneal hemorrhage and arterial dissection/occlusion or emboli)
* Malignant arrhythmias including sustained ventricular arrhythmias and persistent bradycardia (\< 50 beats per minute due to sinus node or atrioventricular conduction system abnormalities, second- /third-degree atrioventricular block) after PCI
* Ongoing hemodynamic instability (systolic blood pressure \<90 mmHg, elevated lactate concentrations, need for inotropes or vasopressors)
* Ongoing respiratory instability defined by Killip class \>I (rales, pulmonary edema)
* Ongoing quantitative disorders of consciousness (somnolence, sopor, coma)
* Acute kidney injury defined by Kidney Disease Improving Global Outcomes (KDIGO) stages 2 and 3
* Pregnancy
* Untreated critical non-culprit lesions requiring revascularization during index hospitalization not allowing fast discharge
* Immobility/limited mobility or social circumstances that prevent fast discharge assessed by an interprofessional care team
Primary outcome measure(s)
MACE — From the date of randomization until the first documented event during the follow-up period (up to 12 months). MACE is defined as a composite of all-cause death, myocardial re-infarction and unscheduled cardiovascular re-hospitalization.
Trial sites (8)
Facility
City
Region
Status
Hospital Wiener Neustadt
Wiener Neustadt
Lower Austria
Recruiting
Cardinal Schwarzenberg Hospital Schwarzach
Schwarzach im Pongau
Schwarzach Im Pongau
Not Yet Recruiting
Paracelsus Medical University Salzburg
Salzburg
State of Salzburg
Recruiting
Medical University of Graz
Graz
Styria
Recruiting
Medical University of Innsbruck
Innsbruck
Tyrol
Recruiting
University Teaching Hospital Wels-Grieskirchen
Wels
Upper Austria
Recruiting
Academic Teaching Hospital Feldkirch
Feldkirch
Vorarlberg
Recruiting
Ludwig Maximilian University Munich
Munich
Bavaria
Not Yet Recruiting
More Medical University Innsbruck trials in Germany
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.